Literature DB >> 5781098

A ten-year study of 5-flurouracil in disseminated breast cancer with clinical results and survival times..

F J Ansfield, G Ramirez, S Mackman, G T Bryan, A R Curreri.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1969        PMID： 5781098

Source DB:  PubMed          Journal:  Cancer Res        ISSN： 0008-5472            Impact factor:   12.701


× No keyword cloud information.
  8 in total

Review 1.  Systemic therapy in breast cancer: efficacy and cost utility.

Authors:  J F Corry; P E Lønning
Journal:  Pharmacoeconomics       Date:  1994-03       Impact factor: 4.981

2.  Adrenalectomy for metastatic mammary cancer.

Authors:  J S Horsley; E M Alrich; H F Sears; C B Wright
Journal:  Ann Surg       Date:  1971-06       Impact factor: 12.969

3.  Systemic chemotherapy of mammary carcinoma.

Authors:  W W Shingleton; N Sedransk; R O Johnson
Journal:  Ann Surg       Date:  1971-06       Impact factor: 12.969

4.  Biochemical determinants of tumor sensitivity to 5-fluorouracil: ultrasensitive methods for the determination of 5-fluoro-2'-deoxyuridylate, 2'-deoxyuridylate, and thymidylate synthetase.

Authors:  R G Moran; C P Spears; C Heidelberger
Journal:  Proc Natl Acad Sci U S A       Date:  1979-03       Impact factor: 11.205

5.  Indications for hypophysectomy in diabetic retinopathy and cancer of the breast and prostate.

Authors:  S Saglam; C B Wilson; R J Seymour
Journal:  Calif Med       Date:  1970-08

6.  Cyclical combination chemotherapy for advanced breast carcinoma.

Authors:  G P Canellos; V T Devita; G L Gold; B A Chabner; P S Schein; R C Young
Journal:  Br Med J       Date:  1974-02-09

7.  Antitumor efficacy of 7 beta, 17 alpha-dimethyltestosterone (Calusterone) in advanced female breast cancer.

Authors:  G S Gordan; A Halden; R M Walter
Journal:  Calif Med       Date:  1970-09

8.  A phase I trial of docetaxel and 5-day continuous infusion of 5-fluorouracil in patients with advanced or recurrent breast cancer.

Authors:  M Ando; T Watanabe; Y Sasaki; D F Ying; Y Omuro; N Katsumata; M Narabayashi; Y Tokue; H Fujii; T Igarashi; H Wakita; T Ohtsu; K Itoh; I Adachi; T Taguchi
Journal:  Br J Cancer       Date:  1998-06       Impact factor: 7.640
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.